Sort
51,593 grants matching “hepatitis”
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States
$665,811Becky Lynn Genberg · Johns Hopkins University · R01 · FY2020 · DA
"A microbiome-dependent bile acid metabolite improves type 2 diabetes."
$665,780Eric Garland Sheu · Brigham And Women'S Hospital · R01 · FY2023 · DK
NIH Director's Pioneer Award
$665,763Nathan D Wolfe · Metabiota, Inc · DP1 · FY2008 · OD
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
$665,725Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2022 · HL
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
$665,665William Robert Jarnagin · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Viral Hepatitis Prevention and Surveillance
$665,639Debra S. Blog · Nysdoh/Health Research, Inc. · U51 · FY2015 · PS
Liver Pathobiology and Gene Therapy Research Core Center
$665,559Allan W Wolkoff · Albert Einstein College Of Medicine · P30 · FY2018 · DK
Viral Determinants of Chronic Hepacivirus Infection
$665,540Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI
Viral Determinants of Chronic Hepacivirus Infection
$665,540Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · AI
Accelerating novel countermeasures against RNA viruses through repurposing
$665,382Shirit Einav · Stanford University · U19 · FY2017 · AI
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
$665,380Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2022 · CA
HCV-specific T cell response
$665,354Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R37 · FY2011 · AI
Clinical Trial of Short Course vs. INH for LTBI in Jail
$665,347Mary Castle White · University Of California, San Francisco · U01 · FY2007 · AI
Obesity risk in African American women is determined by a diet-by-phenotype interaction
$665,347Barbara A. Gower · University Of Alabama At Birmingham · R01 · FY2018 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
$665,303Claude B Sirlin · University Of California, San Diego · R01 · FY2017 · DK
"A microbiome-dependent bile acid metabolite improves type 2 diabetes."
$665,301Eric Garland Sheu · Brigham And Women'S Hospital · R01 · FY2022 · DK
Alcohol, iNOS upregulation , leaky gut &liver disease
$665,228Rush University Medical Center · R01 · FY2005 · AA
Alcohol, iNOS upregulation , leaky gut & liver disease
$665,138Ali Keshavarzian · Rush University Medical Center · R01 · FY2006 · AA
Role of liver and visceral fat in glucose and lipid metabolism during pregnancy
$665,049Kimberly Kristine Vesco · Kaiser Foundation Research Institute · R01 · FY2016 · DK
Role of G protein-coupled receptors in regulating glucose and energy homeostasis
$665,035Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
$664,962Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2018 · CA
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
$664,926Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2023 · HL
Impact of the New York State Medicaid Value-Based Payment Model on Opioid Use Treatment and Equity
$664,922Michael Flores · Cambridge Health Alliance · R01 · FY2024 · DA
Organogenesis of Ectopic Tissue in Lymph Node
$664,918Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · DK
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERS
$664,886Johns Hopkins University · R01 · FY2002 · DA